This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Okamoto, H.; Hayaishi, O.: Flavin adenine dinucleotide requirement for kynurenine hydroxylase of rat liver mitochondria. Biochem. Biophys. Res. Commun., 29, 394–399 (1967)
Saito, Y.; Hayaishi, O.; Rothenberg, S.: Studies on oxygenases: Enzymatic formation of 3-hydroxy-l-kynurenine from l-kynurenine. J. Biol. Chem., 229, 921–934 (1957)
Nisimoto, Y.; Takeuchi, F.; Shibata, Y.: Molecular properties of l-kynurenine 3-hydroxylase from rat liver mitochondria. J. Biochem., 81, 1413–1425 (1977)
Nisimoto, Y.; Takeuchi, F.; Shibata, Y.: Isolation of l-kynurenine 3-hydroxylase from the mitochondrial outer membrane of rat liver. J. Biochem., 78, 573–581 (1975)
Nishimoto, Y.; Takeuchi, F.; Shibata, Y.: Purification of l-kynurenine 3-hydroxylase by affinity chromatography. J. Chromatogr., 169, 357–364 (1979)
McLean-Bowen, C.A.; Parks, L.W.: Corresponding changes in kynurenine hydroxylase activity, membrane fluidity, and sterol composition in Saccharomyces cerevisiae mitochondria. J. Bacteriol., 143, 1325–1333 (1981)
Schott, H.H.; Staudinger, H.: The regulatory function of l-kynurenine 3-hydroxylase (EC 1.14.1.2) for the biosynthesis of pyridine nucleotides in anaerobically and aerobically grown Saccharomyces cerevisiae. Hoppe-Seyler’s Z. Physiol. Chem., 352, 1654–1658 (1971)
Saito, K.; Quearry, B.J.; Saito, M.; Nowak, T.S. Jr.; Markey S.P.; Heyes, M.P.: Kynurenine 3-hydroxylase in brain: species activity differences and effect of gerbil cerebral ischemia. Arch. Biochem. Biophys., 307, 104–109 (1993)
Pinamonti, S.; Chiarelli-Alvisi, G.: Kynurenine-3-hydroxylase of Schistocera gregaria. Insect Biochem., 4, 9–16 (1974)
Stratakis, E.: Subcellular localization and properties of kynurenine 3-hydroxylase from eggs of Ephestia kuhniella Z. J. Comp. Physiol., 141, 451–456 (1981)
Shin, M.; Sano, K.; Umezawa, C.: Inhibition of l-kynurenine 3-hydroxylase from Saccharomyces carlsbergensis by α-keto acid derivatives of branched chain amino acids. J. Nutr. Sci. Vitaminol., 28, 191–201 (1982)
Giordani A.; Pevarello P.; Cini, M.; Bormetti, R.; Greco, F.; Toma, S.; Speciale, C.; Varasi, M.: 4-phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase. Bioorg. Med. Chem. Lett., 8, 2907–2012 (1998)
Speciale, C.; Cini, M.; Wu, H.Q.; Salvati, P.; Schwarcz, R.; Molinari, A.; Calabresi, M.; Varasi, M.: Kynurenic acid-enhancing and anti-ischemic effects of the potent kynurenine 3-hydroxylase inhibitor FCE28833 in rodents. Adv. Exp. Med. Biol., 398, 221–227 (1996)
Rover, S.; Cesura, A.M.; Huguenin, P.; Kettler, R.; Szente, A.: Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase. J. Med. Chem., 40, 4378–4385 (1997)
Uemura, T.; Hirai, K.: Purification of l-kynurenine 3-monooxygenase from mitochondrial outer membrane of pig liver. Adv. Exp. Med. Biol., 467, 619–623 (1999)
Cozzi, A.; Carpenedo, R.; Moroni, E: Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. J. Cereb. Blood Flow Metab., 19, 771–777 (1999)
Heidempergher, E; Pevarello, E; Pillan, A.; Pinciroli, V.; Torre, A.D.; Speciale, C.; Marconi, M.; Cini, M.; Toma, S.; Greco, E; Varasi, M.: Pyrrolo[3,2-c]quinoline derivates: a new class of kynurenine-3-hydroxylase inhibitors. Farmaco, 54, 152–160 (1999)
Breton, J.; Avanzi, N.; Magagnin, S.; Covini, N.; Magistrelli, G.; Cozzi, L.; Isacchi, A.: Functional characterization and mechanism of action of recombinant human kynurenine 3-hydroxylase. Eur. J. Biochem., 267, 1092–1099 (2000)
Chiarugi, A.; Cozzi, A.; Massacesik L.; Moroni, F.: Kynurenine 3-momooxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. Neurosci., 102, 687–695 (2001)
Drysdale, M.J.; Hind, S.L.; Jansen, M.; Reinhard, J.F. Jr: Synthesis and SAR of 4-aryl-2-hydroxy-4-oxobut-2-enoic acids and esters and 2-amino-4-aryl-4-oxobut-2-enoic acids and esters: Potent inhibitors of kynurenine-3-hydroxylase as potential neuroprotective agents. J. Med. Chem., 43, 123–127 (2000)
Urenjak, J.; Obrenowitch, T.P.: Kynurenine 3-hydroxylase inhibition in rats: Effects on extracellular kynurenic acid concentration and N-methyl-d-aspartate-induced depolarisation in the striatum. J. Neurochem., 75, 2427–2433 (2000)
Alberati-Giani, D.; Cesuura, A.M.; Broger, C.; Warren, W.D.; Rover, S.; Malherbe, P.: Cloning and functional expression of human kynurenine 3-monooxygenase. FEBS Lett., 410, 407–412 (1997)
Pellicciari, R.; Natalini, B.; Costantino, G.; Mahmoud, M.R.; Mattoli, L.; Sadeghpour, B.M.; Moroni, E; Chiarugi, A.; Carpenedo, R.: Modulation of the kynurenine pathway in search for new neruoprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoys)alanine, a potent inhibitor of kynurenine-3-hydroxylase. J. Med. Chem., 37, 647–655 (1994)
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2006). Kynurenine 3-monooxygenase. In: Class 1 Oxidoreductases XI. Springer Handbook of Enzymes, vol 26. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-37708-5_48
Download citation
DOI: https://doi.org/10.1007/3-540-37708-5_48
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-26586-3
Online ISBN: 978-3-540-37708-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)